These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22926711)

  • 1. Will the new advantages provided by PET in myocardial perfusion imaging help nuclear cardiology survive the test of time against conventional radiological techniques?
    Caobelli F; Farina D; Pizzocaro C; Guerra UP
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1970-2. PubMed ID: 22926711
    [No Abstract]   [Full Text] [Related]  

  • 2. ⁸²Rb PET/CT: entering a new area of myocardial perfusion imaging?
    Valenta I; Schindler TH
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1231-2. PubMed ID: 22652982
    [No Abstract]   [Full Text] [Related]  

  • 3. ⁸²Rb PET myocardial perfusion imaging is superior to ⁹⁹mTc-labelled agent SPECT in patients with known or suspected coronary artery disease.
    Flotats A; Bravo PE; Fukushima K; Chaudhry MA; Merrill J; Bengel FM
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1233-9. PubMed ID: 22648514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial perfusion scintigraphy using rubidium-82 positron emission tomography.
    Arumugam P; Tout D; Tonge C
    Br Med Bull; 2013; 107():87-100. PubMed ID: 23966422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial perfusion in patients with suspected coronary artery disease: comparison between 320-MDCT and rubidium-82 PET.
    Dantas RN; Assuncao AN; Marques IA; Fahel MG; Nomura CH; Avila LFR; Giorgi MCP; Soares J; Meneghetti JC; Parga JR
    Eur Radiol; 2018 Jun; 28(6):2665-2674. PubMed ID: 29352381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redistribution of myocardial perfusion after coronary sinus reducer implantation demonstrated by rubidium-82 positron emission tomography.
    Cheng K; Tan ST; Wechalekar K; Keramida G; de Silva R
    J Nucl Cardiol; 2024 Mar; 33():101803. PubMed ID: 38219971
    [No Abstract]   [Full Text] [Related]  

  • 7. Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging.
    Ghotbi AA; Kjaer A; Hasbak P
    Clin Physiol Funct Imaging; 2014 May; 34(3):163-70. PubMed ID: 24028171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of Myocardial Blood Flow With Positron Emission Tomography and Single-Photon Emission Computed Tomography for Diagnosis of Cardiac Allograft Vasculopathy.
    Ruddy TD; Wells RG
    Circ Cardiovasc Imaging; 2023 Jun; 16(6):e015593. PubMed ID: 37313747
    [No Abstract]   [Full Text] [Related]  

  • 9. What should we expect in a prognosis study in 2012?
    Hachamovitch R
    J Nucl Cardiol; 2012 Oct; 19(5):883-6. PubMed ID: 22936467
    [No Abstract]   [Full Text] [Related]  

  • 10. PET should not replace routine SPECT MPS for the assessment of patients with known or suspected CAD.
    Stirrup JE; Underwood SR
    J Nucl Cardiol; 2017 Dec; 24(6):1960-1964. PubMed ID: 28836225
    [No Abstract]   [Full Text] [Related]  

  • 11. PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected CAD: Pro.
    Maddahi J; Packard RRS
    J Nucl Cardiol; 2017 Dec; 24(6):1955-1959. PubMed ID: 28397181
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of radiolabeled compounds for myocardial perfusion imaging.
    Lin X; Zhang J; Wang X; Tang Z; Zhang X; Lu J
    Curr Pharm Des; 2012; 18(8):1041-57. PubMed ID: 22272824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECT Myocardial Perfusion Imaging: Poststress, End Systolic Images and the Ongoing Effort to Improve Diagnostic Accuracy.
    Gewirtz H
    J Nucl Med; 2015 Dec; 56(12):1813-4. PubMed ID: 26315833
    [No Abstract]   [Full Text] [Related]  

  • 14. Predicting outcomes in heart transplantation: PET project or actionable data.
    Givertz MM
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):857-9. PubMed ID: 25406196
    [No Abstract]   [Full Text] [Related]  

  • 15. Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET.
    Di Carli MF
    J Nucl Med; 2023 Nov; 64(Suppl 2):3S-10S. PubMed ID: 37918841
    [No Abstract]   [Full Text] [Related]  

  • 16. When should myocardial perfusion imaging be a first-test choice?
    Al Rifai M; Winchester D
    J Nucl Cardiol; 2024 Mar; 33():101824. PubMed ID: 38360263
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and nature of extracardiac findings in PET/CT myocardial perfusion imaging.
    David S; Packard RRS
    J Nucl Cardiol; 2023 Aug; 30(4):1469-1473. PubMed ID: 37012524
    [No Abstract]   [Full Text] [Related]  

  • 18. Semi-quantitative assessment of ischemia with rubidium-82 PET myocardial perfusion imaging.
    Borren NM; Gerritse TJ; Ottervanger JP; Mouden M; Timmer JR; van Dalen JA; Jager PL; van Dijk JD
    J Nucl Cardiol; 2022 Dec; 29(6):3155-3162. PubMed ID: 34970710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To quantify or not to quantify, that is the question: Semi-quantitative vs. visual analysis of Rb-82 myocardial perfusion imaging PET.
    Rischpler C; Kersting D; Nekolla SG
    J Nucl Cardiol; 2022 Dec; 29(6):3163-3165. PubMed ID: 35274212
    [No Abstract]   [Full Text] [Related]  

  • 20. Semi-quantitative myocardial perfusion measured by computed tomography in patients with refractory angina: a head-to-head comparison with quantitative rubidium-82 positron emission tomography as reference.
    Qayyum AA; Kühl JT; Kjaer A; Hasbak P; Kofoed KF; Kastrup J
    Clin Physiol Funct Imaging; 2017 Sep; 37(5):481-488. PubMed ID: 26625937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.